Xtandi 80 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FPAQD
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,339
Award facts
- Contract value 100% obligated
- $8,339.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $8,339.18 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 60 tablets of Xtandi 80 mg. The award was issued on April 24, 2025, with an ultimate completion date of April 25, 2025, and carries no set-aside designation. This delivery order represents a discrete pharmaceutical supply transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA, valued at $499,999,999 and valid through November 2026.
DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, providing branded and generic prescription drugs, biologics, and medical consumables to military and federal healthcare facilities nationwide. The company's SPE2DB Indefinite Delivery Contract with DLA enables the issuance of firm fixed-price delivery orders across a comprehensive portfolio of pharmaceutical products supporting Department of Defense healthcare requirements. Xtandi, an oncology treatment medication, aligns with the company's demonstrated capability to supply specialized pharmaceutical products and prescription medications to federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FPAQD?
SPE2DB25FPAQD was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on April 24, 2025.
How much is contract SPE2DB25FPAQD worth?
The government has obligated $8,339 on SPE2DB25FPAQD.
Is contract SPE2DB25FPAQD an order under another contract?
Yes. SPE2DB25FPAQD is a delivery order under SPE2DB25D9336, an indefinite delivery contract.
Was contract SPE2DB25FPAQD competed?
The extent of competition for SPE2DB25FPAQD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award